Vanguards of Healthcare by Bloomberg Intelligence

Bloomberg

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Vanguards of Healthcare by Bloomberg Intelligence

Biolinq Introduces New Microsensor Tech For Next Chapter of Glucose and Analyte Detection

Episode discussion: BioLink CEO Rich Yang details Shine sensor tech, OTC clearance, and insulin dosing roadmap

Speakers’ claims: BioLink CEO Rich Yang explains that the Shine sensor uses a 2mm silicon wafer with seven micro-probes to access the papillary dermis, eliminating hypodermic needles. He highlights the company's recent FDA OTC clearance and strategy to target the 90-95% of Type 2 diabetics not on insulin. Yang discusses using real-time LED feedback for cognitive restructuring and manufacturing advantages via semiconductor foundries. The company plans a pivotal trial for insulin dosing claims, targeting FDA submission next year, while developing a second-generation device with doubled electrode density.

Medical DevicesDiabetesCGM
41 min0 assets17 claims to verify
Vanguards of Healthcare by Bloomberg Intelligence

Akido Bets AI Can Break Healthcare’s Scarcity Problem

Episode discussion: Akido Labs CEO claims AI can deliver concierge-quality healthcare to all by breaking scarcity through Scope AI.

Speakers’ claims: Akido Labs CEO Prashant Simant explains how the company evolved from a data platform to a full-stack care delivery organization to leverage predictive models for patient outcomes. He highlights Scope AI, a neural network enabling software-based cardiology visits and clinical decision support for non-medical case managers. Simant claims the system achieves 93.6% accuracy and has reduced emergency department utilization by 50% in their street medicine program. He predicts that within five years, AI and wearables will make high-quality healthcare accessible to everyone, similar to the 'Jeff Bezos model.' The company plans to expand to 50 markets, focusing on value-based care and partnerships in underserved populations.

Artificial IntelligenceHealthcareValue-Based Care
44 min0 assets20 claims to verify